Trial Profile
Myocardial stress perfusion magnetic resonance in a pediatric and young adult population using regadenoson
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Sep 2017
Price :
$35
*
At a glance
- Drugs Regadenoson (Primary)
- Indications Coronary disorders
- Focus Adverse reactions; Therapeutic Use
- 28 Sep 2017 New trial record